| NCT05543928 | Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism | TERMINATED | PHASE3 | 2023-01-31 | 2024-06-19 | 2024-06-19 |
| NCT04551911 | Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19 | COMPLETED | PHASE2 | 2020-11-02 | 2021-10-08 | 2021-10-08 |
| NCT04063644 | Quality of Life and Visual Acuity of Visglyc Eye Drops on Dry Eye Patients | COMPLETED | NA | 2019-05-30 | 2020-12-22 | 2020-12-22 |
| NCT03810664 | A Clinical Study Investigating the Comparability of Somatrogon in Two Different Drug Product Presentations | COMPLETED | PHASE1 | 2019-01-18 | 2019-04-19 | 2019-04-19 |
| NCT03660800 | Pharmacokinetics and Safety Study of CTAP101 Capsules in Japanese and Non-Japanese Healthy Subjects and Non-Japanese Healthy Subjects | COMPLETED | PHASE1 | 2018-08-20 | 2019-01-22 | 2018-10-24 |
| NCT03602261 | Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI | TERMINATED | PHASE2 | 2018-07-09 | 2021-02-24 | 2021-02-24 |
| NCT03588884 | Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease 3-4 and Vitamin D Insufficiency | COMPLETED | PHASE4 | 2018-06-08 | 2020-04-24 | 2020-04-24 |
| NCT03406377 | Effects and Safety of OPK-88003 Dose Escalation in Type 2 Diabetes Subjects | COMPLETED | PHASE2 | 2018-04-02 | 2019-06-27 | 2019-03-08 |
| NCT03297398 | Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) | TERMINATED | PHASE2 | 2018-02-21 | 2019-06-10 | 2019-04-18 |
| NCT03762408 | Efficacy and Safety of a Intra-articular Injection, ENKO1, in Patients With Symptomatic Knee Osteoarthritis. | COMPLETED | NA | 2017-12-15 | 2020-05-29 | 2020-05-29 |
| NCT03874013 | Safety and Efficacy Study of MOD-4023 to Treat Children With Growth Hormone Deficiency | COMPLETED | PHASE3 | 2017-12-07 | 2020-03-06 | 2020-03-06 |
| NCT02919800 | A Single-dose, Dose-escalation Study of a Long-acting MOD-5014 in Healthy Adult Male | COMPLETED | PHASE1 | 2017-01-22 | 2018-02-21 | 2018-02-21 |
| NCT02968004 | Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children | COMPLETED | PHASE3 | 2016-12 | 2024-05 | 2019-08 |
| NCT02692781 | A Single-dose, Dose-escalation Study of a Long-acting MOD-6031 in Healthy Overweight or Obese Subjects | COMPLETED | PHASE1 | 2016-02 | 2016-12-15 | 2016-12-15 |
| NCT02418793 | A Study of a Long-Acting r-Factor 7a (Factor VIIa) in Adult Men With Hemophilia A or B | COMPLETED | PHASE1 | 2015-05 | 2018-09 | 2018-09 |
| NCT03355651 | Efficacy and Tolerability of a Nutritional Supplement, Plactive Progen, in ACL Reconstruction | COMPLETED | NA | 2015-03-09 | 2017-03-03 | 2017-02-01 |
| NCT02418767 | Pharmacokinetics and Pharmacodynamics of Long Acting Human Growth Hormone (hGH) Product (MOD-4023) in Healthy Caucasian and Japanese Volunteers | COMPLETED | PHASE1 | 2015-01 | 2015-06 | 2015-03 |
| NCT02274623 | Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid | COMPLETED | PHASE1 | 2014-12 | 2017-03-17 | 2017-02-27 |
| NCT02188303 | A Study of LY2944876 in Healthy Japanese and Non-Japanese Participants | TERMINATED | PHASE1 | 2014-07 | 2014-12 | 2014-12 |
| NCT02119819 | A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes | COMPLETED | PHASE2 | 2014-04 | 2015-10 | 2015-08 |
| NCT02500316 | Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children | COMPLETED | PHASE2 | 2014-02 | 2023-11 | 2023-11 |
| NCT01791725 | A 4-Week Safety Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia | COMPLETED | PHASE2 | 2013-09 | 2014-06 | 2014-06 |
| NCT01909479 | A Phase 3, Multicenter Study To Evaluate The Efficacy And Safety Of MOD-4023 In Adults With Growth Hormone Deficiency | TERMINATED | PHASE3 | 2013-06 | 2018-08 | 2016-08 |
| NCT02282813 | Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002 | COMPLETED | PHASE3 | 2013-04 | 2015-05 | 2015-05 |
| NCT01766336 | A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease | TERMINATED | PHASE2 | 2013-01 | 2015-08 | 2015-08 |
| NCT01453634 | Four Week, Pharmacodynamic/Pharmacokinetic, Efficacy, and Safety Study of Lunacalcipol (CTA018) | WITHDRAWN | PHASE2 | 2013-01 | 2013-07 | 2013-07 |
| NCT01704079 | Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency | COMPLETED | PHASE3 | 2012-11 | 2014-09 | 2014-08 |
| NCT01735630 | Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease | COMPLETED | PHASE2 | 2012-11 | 2015-05 | 2015-05 |
| NCT01651000 | Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency | COMPLETED | PHASE3 | 2012-09 | 2014-07 | 2014-07 |
| NCT01674010 | Safety and Efficacy Study of ELND005 as an Adjunctive Maintenance Treatment in Bipolar I Disorder | TERMINATED | PHASE2 | 2012-08 | 2014-06 | 2014-06 |
| NCT01592500 | Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children | COMPLETED | PHASE2 | 2012-02 | 2015-07 | 2015-07 |
| NCT01357421 | Effects of TT301 on Cytokine Levels Post Endotoxin Challenge | COMPLETED | PHASE1 | 2011-05 | 2011-06 | 2011-06 |
| NCT01219855 | Safety/Efficacy Study of CTAP101 in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism (SHPT) | COMPLETED | PHASE2, PHASE3 | 2010-10 | 2011-11 | 2011-11 |
| NCT01225666 | MOD-4023 (Long-Lasting Human Growth Hormone (hGH)) Study in Growth Hormone Deficient Adults (GHDA) | COMPLETED | PHASE2 | 2010-08 | 2012-04 | 2011-07 |
| NCT00557791 | Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD (CARBON) | WITHDRAWN | PHASE3 | 2009-11 | 2012-07 | 2011-07 |
| NCT01060722 | MOD-4023 Study in Healthy Male Volunteers | COMPLETED | PHASE1 | 2009-10 | 2010-01 | 2010-01 |
| NCT00934050 | ELND005 Long-Term Follow-up Study in Subjects With Alzheimer's Disease | COMPLETED | PHASE2 | 2009-06 | 2011-06 | 2011-06 |
| NCT00888069 | Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects | COMPLETED | PHASE1 | 2009-05 | 2009-12 | 2009-11 |
| NCT00834223 | A Prospective, Multicenter, Open-label, Safety and Preliminary Efficacy Study of the Surgical Implantation of OPKO's Glaucoma Drainage Device (AquashuntTM) in Patients With Refractory Chronic Forms of Open Angle Glaucoma (OAG) | COMPLETED | NA | 2009-01 | 2010-05 | 2009-09 |
| NCT00792857 | Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT) | COMPLETED | PHASE1 | 2008-11 | 2009-10 | 2009-09 |
| NCT00742716 | Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease | COMPLETED | PHASE2 | 2008-10 | 2010-06 | 2010-02 |
| NCT00743002 | A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione | COMPLETED | PHASE2 | 2008-08 | 2009-12 | 2009-12 |
| NCT00568776 | ELND005 in Patients With Mild to Moderate Alzheimer's Disease | COMPLETED | PHASE2 | 2007-12 | 2010-05 | 2010-05 |
| NCT00499590 | Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD | TERMINATED | PHASE3 | 2007-08 | 2009-05 | 2009-03 |
| NCT00384098 | Safety and Efficacy of Topically Applied CTA018 in Plaque Psoriasis | COMPLETED | PHASE2 | 2006-09 | 2007-05 | 2007-05 |
| NCT00306904 | Safety and Efficacy Study of Small Interfering RNA Molecule (Cand5) to Treat Diabetic Macular Edema | COMPLETED | PHASE2 | 2006-01 | 2007-12 | 2007-09 |
| NCT00239187 | A Study in Type 2 Diabetic Patients With Repeated Doses of E1 in Combination With G1 | COMPLETED | PHASE1 | 2005-09 | 2007-01 | |
| NCT00230854 | Study in Non-responder Hepatitis C Genotype 1 Patients With EMZ702, Pegylated Interferon and Ribavirin | COMPLETED | PHASE1 | 2005-08 | 2007-07 | |
| NCT00259753 | Safety and Efficacy Study of Small Interfering Ribonucleic Acid (RNA) Molecule (Cand5) to Treat Wet Age-Related Macular Degeneration | COMPLETED | PHASE2 | 2005-07 | 2007-12 | 2007-12 |
| NCT00239148 | A Study in Type 1 Diabetic Patients With Repeated Doses of E1 in Combination With G1 | COMPLETED | PHASE1 | 2005-06 | 2006-12 | |
| NCT00722384 | Open Label Study for the Evaluation of Tolerability of Five Dose Levels of Cand5 | COMPLETED | PHASE1 | 2004-08 | 2007-12 | 2007-08 |